Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110627769A reveals mild nicotine synthesis. Offers cost reduction and high purity for electronic chemical manufacturing and pharmaceutical intermediates.
Patent CN106366010B reveals a safer halosilane reduction method for high-purity Saxagliptin intermediates, offering significant cost and supply chain advantages.
Patent CN106083811A details enzymatic synthesis for high purity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107383139A reveals novel protecting groups for Obeticholic acid intermediates improving purification yield and supply chain stability for pharmaceutical manufacturing.
Patent CN104650022A details a novel Nebivolol synthesis avoiding column chromatography. Enhance supply chain reliability and reduce API manufacturing costs with scalable routes.
Advanced patent CN102341367B details a novel two-step synthesis for halogen-substituted benzene dimethanol, offering superior purity and cost-effective manufacturing for global supply chains.
Patent CN103936767B details high-yield synthesis for Ticagrelor intermediates. Offers scalable, cost-effective manufacturing solutions for global pharmaceutical supply chains.
Patent CN108997229A reveals mild synthesis for high-purity intermediates. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturing partners.
Patent CN115109759A reveals engineered carbonyl reductases achieving 600g/g S/C ratio. Discover cost-effective biocatalytic routes for chiral alcohol production.
Patent CN111454918A details a novel OYE3-Mut mutant for >99% ee (R)-citronellal, offering cost-effective biocatalytic solutions for flavor and pharma intermediates.
Patent CN111925330A reveals a high-yield Altimezole preparation method eliminating palladium catalysts, offering cost reduction and scalable veterinary intermediate manufacturing.
Patent CN111235123A reveals a novel carbonyl reductase enabling high-substrate loading biocatalysis, offering significant cost reduction and purity advantages for pharmaceutical manufacturing.
Patent CN111100851B discloses high-efficiency TbSADH mutants for synthesizing chiral biaryl alcohols with >99% ee, offering a green alternative to metal catalysis.
Novel LsCR mutant enables efficient synthesis of chiral alcohols for anticoagulants. Enhanced stability and activity reduce manufacturing costs for pharmaceutical intermediates.
Patent CN110225904A details a modular synthesis for cytotoxic benzodiazepine derivatives, offering improved purity and scalable manufacturing for antibody-drug conjugate intermediates.
Novel preparation method for Bambuterol Impurity C ensures high purity reference standards and supply chain stability for pharmaceutical manufacturing.
Patent CN108147946A reveals a cost-effective iron reduction route for 4-phenylphenol, offering supply chain stability and purity advantages for agrochemical manufacturing.
Patent CN116283706B details a scalable synthesis method for Nirmatrelvir intermediates offering high purity and cost reduction for pharmaceutical supply chains.
Novel lactone-opening route for Tolterodine tartrate. Reduces steps, eliminates harsh reagents, ensures high purity for commercial scale-up.
Patent CN116283706B reveals optimized synthesis for namatevir intermediates ensuring high purity and scalable production for global supply chains.